Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice
- Psychopharmacology (Berl). 2015 Mar;232(5):931-42. doi: 10.1007/s00213-014-3728-6.
- 1. Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Lublin, Poland, [email protected].
Rationale: Imperatorin, a naturally occurring furanocoumarin, inactivates gamma-aminobutyric acid transaminase and inhibits acetylcholinesterase activity.
Objectives: The purpose of our experiment was to examine the influence of imperatorin on cognitive impairment and oxidative stress in the brain induced by scopolamine in male Swiss mice.
Methods: In the present studies, we used scopolamine-invoke memory deficit measured in passive avoidance (PA) paradigm as an animal model of Alzheimer disease (AD).
Results: Our finding revealed that imperatorin administered acutely at the doses of 5 and 10 mg/kg prior to the injection of scopolamine (1 mg/kg) improved memory acquisition and consolidation impaired by scopolamine. Furthermore, repeatable (7 days, twice daily) administration of the highest dose of imperatorin (10 mg/kg) significantly attenuated the effects of scopolamine on memory acquisition, whereas the doses of 5 and 10 mg/kg of this furanocoumarin were effective when memory consolidation was measured. Imperatorin, administered with scopolamine, increased antioxidant Enzymes activity and decreased concentration of malondiamide, an indicator of lipid peroxidation level.
Conclusions: These results demonstrate that imperatorin may offer protection against scopolamine-induced memory impairments and possesses antioxidant properties, thus after further preclinical and clinical studies this compound may provide an interesting approach in pharmacotherapy, as well as prophylactics of AD.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease